Biomea Fusion
Price & Volume
Stats
See more52W Range | $0.87-$3.96 |
Market Cap | $86.2M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.25 |
News
See moreYahoo Finance • 2 months ago
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
Yahoo Finance • 2 months ago
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
Yahoo Finance • 2 months ago
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
Yahoo Finance • 2 months ago
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Michael J. M. Hitchcock Ph.D. |
Address | 1599 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 42 |
